网站主页 >> CAS数据库列表 >> 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate
2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate
|
|
- CAS号:
- 1579965-12-0
- 英文名:
- 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate
- 英文别名:
- GSK2983559 free acid;GSK2983559 (compound 3);2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate;Ethanol,2-[[4-(5-benzothiazolylamino)-6-[(1,1-dimethylethyl)sulfonyl]-7-quinazolinyl]oxy]-,dihydrogenphosphate(ester);Ethanol, 2-[[4-(5-benzothiazolylamino)-6-[(1,1-dimethylethyl)sulfonyl]-7-quinazolinyl]oxy]-, 1-(dihydrogen phosphate);inhibit,THP-1 cell,RIP kinase,GSK 2983559,GSK2983559 free acid,Inhibitor,GSK-2983559,RIPK,Receptor-interacting protein kinases,GSK-2983559 free acid,GSK2983559
- 中文名:
- 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate
- 中文别名:
- 化合物 T11492;GSK2983559磷酸酯;GSK2983559(化合物3);化合物GSK2983559 FREE ACID;2-((4-(苯并[D]噻唑-5-基氨基)-6-(叔丁基磺酰基)喹唑啉-7-基)氧基)乙基 磷酸二氢酯
- CBNumber:
- CB93054278
- 分子式:
- C21H23N4O7PS2
- 分子量:
- 538.53
- MOL File:
- 1579965-12-0.mol
|
|
|
2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate化学性质
-
沸点:
-
823.6±75.0 °C(Predicted)
-
|
-
密度:
-
1.537±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
DMF: slightly soluble; DMSO: 1 mg/ml; PBS (pH 7.2): 1 mg/ml
-
|
-
形态:
-
A crystalline solid
-
|
-
酸度系数(pKa):
-
1.76±0.10(Predicted)
-
|
-
颜色:
-
Light yellow to yellow
-
|
2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate性质、用途与生产工艺
GSK2983559 (compound 3, RIP2 kinase inhibitor 1, RIPK2-IN-1)是一种有效的receptor interacting protein 2 (RIP2) kinase抑制剂,具有良好的激酶特异性。
Target | Value |
RIP2 kinase
()
|
2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/11/08 | HY-112038 | 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate GSK2983559 free acid | 1579965-12-0 | 5mg | 1331元 |
2024/11/08 | HY-112038 | 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate GSK2983559 free acid | 1579965-12-0 | 10mg | 1933元 |
2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate
生产厂家
1579965-12-0, 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate 相关搜索:
- 抑制剂
- 合成有机化合物配体
- C21H23N4O7PS2
- GSK2983559(化合物3)
- 化合物GSK2983559 FREE ACID
- GSK2983559磷酸酯
- 化合物 T11492
- 2-((4-(苯并[D]噻唑-5-基氨基)-6-(叔丁基磺酰基)喹唑啉-7-基)氧基)乙基 磷酸二氢酯
- 1579965-12-0
- inhibit,THP-1 cell,RIP kinase,GSK 2983559,GSK2983559 free acid,Inhibitor,GSK-2983559,RIPK,Receptor-interacting protein kinases,GSK-2983559 free acid,GSK2983559
- GSK2983559 free acid
- GSK2983559 (compound 3)
- Ethanol,2-[[4-(5-benzothiazolylamino)-6-[(1,1-dimethylethyl)sulfonyl]-7-quinazolinyl]oxy]-,dihydrogenphosphate(ester)
- Ethanol, 2-[[4-(5-benzothiazolylamino)-6-[(1,1-dimethylethyl)sulfonyl]-7-quinazolinyl]oxy]-, 1-(dihydrogen phosphate)
- 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate